RAMM Pharma and MTC Announce Receipt of Conditional Approval to List on the CSE and Provide an Update on Transaction Status TORONTO, Sept. 19, 2019 (GLOBE NEWSWIRE) -- MTC Growth Fund-I Inc. ("MTC") & RAMM Pharma announce that, further to the news releases dated May 3 and 30, 2019, MTC has received conditional...

Ramm Pharma Corp. Announces Completion of Oversubscribed Financings for Gross Proceeds of $35.3 Million NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH US NEWSWIRE SERVICES TORONTO, May 30, 2019 (GLOBE NEWSWIRE) -- Further to its news release dated May 3, 2019 announcing the proposed...

MTC Growth Fund-I Inc. to Acquire Leading Cannabinoid Based Pharmaceutical Company, Complete $24 Million Financing and Corporate Reorganization NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH US NEWSWIRE SERVICES TORONTO, May 03, 2019 (GLOBE NEWSWIRE) -- MTC Growth Fund-I Inc. (“MTC” or the “Corporation”) is pleased to announce that...